» Articles » PMID: 37623898

Effects of Gold Nanoparticles Phytoreduced with Rutin in an Early Rat Model of Diabetic Retinopathy and Cataracts

Overview
Journal Metabolites
Publisher MDPI
Date 2023 Aug 25
PMID 37623898
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy (DR) and cataracts (CA) have an early onset in diabetes mellitus (DM) due to the redox imbalance and inflammation triggered by hyperglycaemia. Plant-based therapies are characterised by low tissue bioavailability. The study aimed to investigate the effect of gold nanoparticles phytoreduced with Rutin (AuNPsR), as a possible solution. Insulin, Rutin, and AuNPsR were administered to an early, six-week rat model of DR and CA. Oxidative stress (MDA, CAT, SOD) was assessed in serum and eye homogenates, and inflammatory cytokines (IL-1 beta, IL-6, TNF alpha) were quantified in ocular tissues. Eye fundus of retinal arterioles, transmission electron microscopy (TEM) of lenses, and histopathology of retinas were also performed. DM was linked to constricted retinal arterioles, reduced endogen antioxidants, and eye inflammation. Histologically, retinal wall thickness decreased. TEM showed increased lens opacity and fibre disorganisation. Rutin improved retinal arteriolar diameter, while reducing oxidative stress and inflammation. Retinas were moderately oedematous. Lens structure was preserved on TEM. Insulin restored retinal arteriolar diameter, while increasing MDA, and amplifying TEM lens opacity. The best outcomes were obtained for AuNPsR, as it improved fundus appearance of retinal arterioles, decreased MDA and increased antioxidant capacity. Retinal edema and disorganisation in lens fibres were still present.

Citing Articles

Natural remedies proposed for the management of diabetic retinopathy (DR): diabetic complications.

Khidr E, Morad N, Hatem S, El-Dessouki A, Mohamed A, El-Shiekh R Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39954069 DOI: 10.1007/s00210-025-03866-w.


Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems.

Ye X, Fung N, Lam W, Lo A Nutrients. 2024; 16(11).

PMID: 38892648 PMC: 11174689. DOI: 10.3390/nu16111715.

References
1.
Meng D, Mei A, Liu J, Kang X, Shi X, Qian R . NADPH oxidase 4 mediates insulin-stimulated HIF-1α and VEGF expression, and angiogenesis in vitro. PLoS One. 2012; 7(10):e48393. PMC: 3483150. DOI: 10.1371/journal.pone.0048393. View

2.
Xiao L, Yang Y, Liu Q, Peng J, Yan J, Peng Q . Visualizing the intellectual structure and recent research trends of diabetic retinopathy. Int J Ophthalmol. 2021; 14(8):1248-1259. PMC: 8342278. DOI: 10.18240/ijo.2021.08.18. View

3.
Xiao A, Zhong H, Xiong L, Yang L, Xu Y, Wen S . Sequential and Dynamic Variations of IL-6, CD18, ICAM, TNF-, and Microstructure in the Early Stage of Diabetic Retinopathy. Dis Markers. 2022; 2022:1946104. PMC: 8813280. DOI: 10.1155/2022/1946104. View

4.
Mills S, Jobling A, Dixon M, Bui B, Vessey K, Phipps J . Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy. Proc Natl Acad Sci U S A. 2021; 118(51). PMC: 8713803. DOI: 10.1073/pnas.2112561118. View

5.
Hsueh Y, Chen Y, Tsao Y, Cheng C, Wu W, Chen H . The Pathomechanism, Antioxidant Biomarkers, and Treatment of Oxidative Stress-Related Eye Diseases. Int J Mol Sci. 2022; 23(3). PMC: 8835903. DOI: 10.3390/ijms23031255. View